Michael Ong, Michael Paul Kolinsky, Kim N. Chi, Sebastien J. Hotte, Michael Donald Brundage, Daniel Joseph Khalaf, David Boren, M. Neil Reaume, Alexander William Wyatt, Wendy R. Parulekar, Keyue Ding, Mariam Jafri. "A randomized phase III trial investigating platinum and taxane chemotherapy in metastatic castration-resistant prostate cancer (mCRPC) patients with alterations in DNA damage response (DDR) genes (OPTION-DDR) CCTG-PR-25 NCT06439225.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps5143